logoOmicsDI
  • Browse
  • Submit Data
  • Databases
  • API

5 Results

Show all   Save search   Copy query

Show results for

  • UnknownUnknown (5)

Publication Date

Release Date

  • Previous page
  • 1 / 1
  • You're on page 1
  • Next page
Sort   by:  
Relevance
 Page size 
10
UnknownTivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial.
Not available
S-EPMC5569677 | biostudies-literature
UnknownRECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis.
Not available
S-EPMC5816475 | biostudies-literature
UnknownInfluence of Alloying Elements on the Mechanical Properties of Anodized Aluminum and on the Adhesion of Copper Metallization.
Not available
S-EPMC8624961 | biostudies-literature
UnknownPhase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4).
Not available
S-EPMC5006123 | biostudies-literature
UnknownNiraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.
Not available
S-EPMC10431499 | biostudies-literature
  • Previous page
  • 1 / 1
  • You're on page 1
  • Next page
Sort   by:  
Relevance
 Page size 
10
OmicsDI is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

EMBL-EBI logoEMBL-EBI logo

OmicsDI Databases

  • PRIDE
  • PeptideAtlas
  • MassIVE
  • JPOST Repository
  • Physiome Model Repository
  • EGA
  • EVA
  • ENA
  • LINCS
  • PAXDB
  • Cell Collective
  • MetaboLights
  • Metabolomics Workbench
  • MetabolomeExpress
  • GNPS
  • BioModels
  • FAIRDOMHub
  • ArrayExpress
  • dbGaP
  • ExpressionAtlas
  • GEO
  • NODE

Information

  • Databases
  • Help
  • API
  • Contact us
  • Code on GitHub
  • Terms of use
  • Submit Data